Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by BigDolphinon Feb 02, 2017 10:20pm

160 Views

Post# 25793043

RE:RE:RE:RE:RE:RE:Zenith - a perspective

There ya go again. Down down down. Interest my @ss. Nothing again for shareholders. Blah blah blah blah. Nothing. More than 10 years with this. They don't give a &hit about us. At all. I'll buy when lower. If not. I'm not going to buy unless I see 10 million shares traded in one day. I still got a bunch in tfsa's. I'm so sick and tired of hearing now would be a bad time to be left out. Here's my advice to anyone new. Don't buy!!!!!

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?